This book has been written from two points of view: firstly, from the viewpoint of those who are involved in the diagnosis and treatment of lymphoid malignancies, who must meet the challenge of integrating the new biological insights into their knowledge of these diseases; and secondly, from the viewpoint of those who are involved in basic biological approaches to malignancy and immunology, who wish to know more about the function of the lymphoid tissues and their malignant diseases. Neoplasia of lymphocytes is a focus for considering many of the most important biological advances impinging on cancer in the past two or three decades, because malignant lymphoproliferative diseases offer unequalled opportunities for studying many aspects of cancer. We probably know more about lymphocytes than other normal cells because of the ease with which they can be obtained. For the same reason we probably know more about malignant lymphocytes. One or other aspect of most of the momentous advances in biology of the past two or three decades has implications for lymphoid malignancies: hybridoma technology and the use of monoclonal antibodies, gene technology, the understanding of oncogenes and growth factors in the control of growth and differentiation, insights into causation of cancer by potent tumour promoters such as the phorbol esters and by viruses, and knowledge of the control of growth function of lymphocytes themselves. Conversely, many of the advances in understanding lym phocytic leukaemias and lymphomas have implications for other cancers.
Sprache
Verlagsort
Verlagsgruppe
Illustrationen
Dateigröße
ISBN-13
978-1-4471-1467-3 (9781447114673)
DOI
10.1007/978-1-4471-1467-3
Schweitzer Klassifikation
1 Cancer Biology.- Development of Cancers from Single Cells.- Diversity of Tumour Cells.- Differentiation of Malignant Cells.- 2 Derangement of the Genome as a Cause of Cancer.- The Chromosomes.- Chromosomal Abnormalities in Cancer.- Susceptibility to Chromosome Damage and Cancer.- Constitutional Cytogenetic Abnormalities.- Fragile Sites.- 3 Derangements of the Mechanisms Controlling Growth.- Cell Cycle.- Signal Transduction.- Immortalisation and Transformation.- Mechanisms Leading to Autonomous Growth.- Differentiation Arrest.- 4 Multiple Steps in the Genesis of a Cancer.- Initiation.- Promotion.- Progression.- Conclusions.- 5 Multifactorial Aetiology of Cancers.- Population and Familial Factors.- Carcinogens.- Radiation.- Viruses.- Viruses in the Causation of Animal Cancers.- Viruses in the Causation of Human Cancers.- Immunodepression and Immunosuppression.- Prolonged Antigenic Stimulation.- 6 Oncogenes.- Translation Products of Oncogenes.- Oncogene Products with Protein Kinase Activity.- GTP-binding Oncogene Products.- Oncogenes Whose Products Bind to DNA.- Oncogene Product with Growth Factor Activity.- Oncogenes Encoding Receptors for Growth Factors.- Oncogenes Whose Products have Undefined Function.- Some Important Non-human Oncogenes.- Aberrations of Oncogenes in Cancer.- Proteins Homologous to Oncogene Products.- Transgenic Mice.- Oncogenes in Human Tumours.- Multiple Oncogene Expression.- Conclusions.- 7 Growth Factors.- Mechanisms of Action of Growth Factors.- Growth Factors in Malignant Transformation.- Growth Factors for Haematopoietic Cells.- Chalones and Other Antiproliferative Factors.- Conclusions.- 8 The Lymphoid Tissues.- Origin of Lymphocytes.- T Lymphocytes.- B Lymphocytes.- NK, ADCC and Lymphokine-activated Killer Cells.- Accessory Cells.- Activation of Macrophages.- Lymphoid Organs and Immunological Function.- Lymphocyte Circulation.- Organisation of Immunological Function.- 9 The Major Histocompatibility Complex.- Tissue Distribution of MHC Products.- MHC Gene Products and Their Specificities.- Immunoregulatory Function of the MHC.- Mixed Lymphocyte Reaction.- Graft Versus Host Reaction.- Association of Diseases with MHC Phenotype.- Conclusions.- 10 T Cell Differentiation.- The Thymus.- T Lymphocytes in Bone Marrow.- T Cells in Lymph Nodes.- T Cell Subsets.- T Cell Receptor.- Genetic Mechanisms in T Cell Differentiation.- T Cell Activation.- Signal Transduction in T Cell Activation.- 11 B Cell Differentiation.- Antigen-independent B Cell Differentiation.- B Lymphocyte Differentiation in Postnatal Life.- Antigen-dependent B Cell Differentiation.- B Cell Subsets.- Immunoglobulin.- Genetic Mechanisms in B Cell Differentiation.- 12 B Cell Activation.- T Cells in B Cell Activation.- Accessory Cells in B Cell Activation.- B Cell Activation by Cross-linking Immunoglobulin.- Soluble Factors in B Cell Activation.- Cellular Events in B Lymphocyte Activation.- Conclusions.- 13 Immunoregulatory Mechanisms.- Systems Controlling Immunological Function.- Suppressor Mechanisms.- Idiotypes.- Immunological Tolerance.- Regulatory Mechanisms in B Cell Malignancies.- 14 Technology of Investigation and Diagnosis.- Hybridoma Technology and Monoclonal Antibodies.- Gene Cloning.- Gene Probing.- Immunodiagnostic Methods.- Immunological Methods.- Immunohistochemical Methods.- Histochemical Stains.- Flow Cytometry.- Ultrastructural Analysis.- Conclusions.- 15 B Cell Neoplasia.- Immunological Abnormalities in Lymphoid Malignancies.- Chromosomal Abnormalities in B Cell Malignancies.- Oncogene Activation in B Cell Neoplasia.- Immunoglobulin Gene Rearrangements.- 16 B Cell Leukaemias.- Acute Lymphoblastic Leukaemia.- B-Chronic Lymphocytic Leukaemia.- B Cell Prolymphocytic Leukaemia.- Hairy Cell Leukaemia.- Chronic Cold Agglutinin Disease.- Lymphoplasmacytoid Lymphoma.- Plasma Cell Dyscrasias.- 17 B Cell Lymphomas.- B Cell Lymphomas of the Deep Cortex.- B Cell Lymphomas of the Superficial Cortex.- B Cell Lymphomas of the Medulla: Plasmacytoma.- Undifferentiated B Cell Lymphomas.- Extranodal B Cell Lymphomas.- Hodgkin's Disease.- 18 T Cell Neoplasia.- Chromosomal Abnormalities in T Cell Malignancies.- Gene Rearrangements in T Cell Malignancies.- 19 T Cell Leukaemias and Lymphomas.- T Cell Neoplasms of the Bone Marrow Compartment.- T Cell Neoplasms of the Thymic Compartment.- T Cell Neoplasms of the Peripheral Compartment.- 20 Treatment, Treatment Failure and Future Possibilities.- Treatment Failure Exemplified by Lymphocytic Leukaemia.- Immunotherapy.- Cytokines and Other Biological Agents.- New Drugs and Other Treatments.- Conclusions.
